Locally Advanced Pancreatic Cancer Recruiting Phase 0 Trials for Irinotecan (DB00762)

Also known as: Pancreatic Carcinoma Stage II / Locally advanced Pancreatic cancer

IndicationStatusPhase
DBCOND0040768 (Locally Advanced Pancreatic Cancer)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03600623Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerTreatment